Pricing Log in Create free account
Friday 6 November 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue
−0.24%
EPS
+2.48%
Free cash flow
+17.4%
Total debt
+37.5%

Quarter to June 2026, against a year earlier

80.02 2.09 −2.55%
Market cap
$33.9B
P/E
13.4×
Fwd P/E
14.2×
Dividend yield
2.59%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Zoetis Inc. (ZTS) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Zoetis Inc. (ZTS) trades at a EV/EBITDA of 10.7×. Over the past ten years it has ranged from 9.4× (October 2026) to 39.4× (December 2021); the current reading is higher than 4% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 12.2× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 15.7× (23.16%)
FY2024 20.4× (21.48%)
FY2023 26.0× 18.57%
FY2022 21.9× (41.81%)
FY2021 37.6× 22.00%
FY2020 30.8× 10.83%
FY2019 27.8× 33.13%
FY2018 20.9× 3.29%
FY2017 20.2× 9.10%
FY2016 18.5× (41.79%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 9.6× (32.91%)
Mar 2026 14.4× (8.29%)
Dec 2025 15.7× (11.73%)
Sep 2025 17.7× (4.97%)
42 more quarters

Against its own ten years

Low 9.4× High 39.4×
Ten-year median 23.6×
Current reading's percentile 4

EV/EBITDA against peers

Company EV/EBITDA
ZTS Zoetis Inc. 10.7×
TAK Takeda Pharmaceutical Co. compare 11.2×
HLN Haleon PLC Sponsored ADR compare 12.2×
VTRS Viatris Inc. compare 12.3×
UTHR United Therapeutics Corporation compare 14.7×
NBIX Neurocrine Biosciences, Inc. compare 16.5×
ELAN Elanco Animal Health Incorporated compare 19.7×
RDY Dr. Reddy's Laboratories Ltd compare 22.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 26.2×
Drug Manufacturers Specialty & Generic industry median 12.2×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ZTS